Company · CIK 0000725363 · SIC 2836 — Biological Products, (No Diagnostic Substances) · NYSE
CEL SCI CORP · CVM
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 25, 2026 PForm 4 → | Aug 26, 8:32 am EDT | Geert R KerstenChief Executive Officer, Director | 100,000 | $1.38 | $138,000 | 316,142 | +46.3% | |
| Jun 30, 2026 AForm 4 → | Jul 1, 8:40 am EDT | Eyal TalorChief Scientific Officer | 2,307 | $1.04 | $2,399 | 9,318 | — | |
| Jun 30, 2026 AForm 4 → | Jul 1, 8:37 am EDT | Patricia B PrichepChief Financial Officer | 4,125 | $1.04 | $4,290 | 17,489 | — | |
| Jun 30, 2026 AForm 4 → | Jul 1, 8:33 am EDT | Geert R KerstenChief Executive Officer, Director | 5,192 | $1.04 | $5,400 | 216,142 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 14, 2026 AForm 4 → | Aug 17, 9:43 am EDT | Robert Eugene WatsonDirector | 110,000 | $0.01 | $1,100 | 137,271 | — | |
| Aug 14, 2026 AForm 4 → | Aug 17, 9:37 am EDT | Bruno Jean-Marie BaillavoineDirector | 110,000 | $0.01 | $1,100 | 138,021 | — | |
| Aug 14, 2026 AForm 4 → | Aug 17, 9:33 am EDT | John CiprianoSenior Vice President | 80,000 | $0.01 | $800 | 118,010 | — | |
| Aug 14, 2026 AForm 4 → | Aug 17, 9:27 am EDT | Eyal TalorChief Scientific Officer | 250,000 | $0.01 | $2,500 | 331,625 | — | |
| Aug 14, 2026 AForm 4 → | Aug 17, 9:23 am EDT | Patricia B PrichepChief Financial Officer | 225,000 | $0.01 | $2,250 | 299,693 | — | |
| Aug 14, 2026 AForm 4 → | Aug 17, 9:19 am EDT | Geert R KerstenChief Executive Officer, Director | 300,000 | $0.01 | $3,000 | 452,380 | — |